Skip to main content
. 2017 Feb 3;13:245–252. doi: 10.2147/NDT.S124448

Table 5.

Questionnaire results at baseline and at 3 months

Measures TG (n=30) CG (n=32) t/F df P-value
MSNQ
 Baseline 29.83±11.99 24.28±11.57 2.41 1.60 0.07
 3 months 23.87±11.83* 25.63±11.83 16.55 1.60 <0.001
FSS
 Baseline 34.73±21.97 28.89±21.79 1.05 1.60 0.29
 3 months 30.51±20.22 29.21±21.94 1.44 1.60 0.24
HADS
Anxiety
 Baseline 8.10±4.18 6.50±3.39 1.66 1.60 0.10
 3 months 5.97±3.15# 7.41±3.44# 17.52 1.60 <0.001
Depression
 Baseline 7.47±3.29 5.75±3.63 2.11 1.60 0.05
 3 months 5.57±3.93 6.13±3.49 12.31 1.60 <0.001
MSQoL-54
Physical
 Baseline 46.43±17.83 63.75±17.27 −3.88 1.60 <0.001
 3 months 52.99±19.20 63.24±16.98 4.57 1.60 <0.05
Mental
 Baseline 47.88±20.19 62.16±16.27 −3.07 1.60 0.03
 3 months 56.39±18.70 67.32±17.06 1.18 1.60 0.28

Notes: All values are raw scores. Comparing baseline with 3 months:

*

P<0.001,

#

P<0.05,

P<0.05 and

P<0.05.

Abbreviations: CG, control group; df, degree of freedom; FSS, Fatigue Severity Scale; HADS, Hospital Anxiety and Depression Scale; MSNQ, Multiple Sclerosis Neuropsychological Questionnaire; MSQoL-54, Multiple Sclerosis Quality of Life-54; TG, treatment group.